The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies

被引：6

作者：

Sun, Xuezheng ^{[1
,8
]}

Abrahamson, Page ^{[2
]}

Ballew, Nicholas ^{[3
]}

Kalilani, Linda ^{[1
]}

Phiri, Kelesitse ^{[3
]}

Bell, Kelly F. ^{[3
]}

Slowley, Alexander ^{[4
]}

Zajac, Magdalena ^{[4
]}

Hofstatter, Erin ^{[5
]}

Stojadinovic, Alexander ^{[3
]}

Silvestro, Angela ^{[5
]}

Wang, Zebin ^{[5
]}

Aziez, Amine ^{[6
]}

Peters, Solange ^{[7
]}

机构：

[1] GSK, Res Triangle Pk, NC USA

[2] Salmon Bay Consulting, Seattle, WA USA

[3] GSK, Collegeville, PA USA

[4] GSK, London, England

[5] GSK, Waltham, MA USA

[6] GSK, Zug, Switzerland

[7] Lausanne Univ Hosp, Dept Oncol, Lausanne, Switzerland

[8] GSK, Oncol Epidemiol Value Evidence & Outcomes, R&D Global Med, 5 Moore Dr, Res Triangle Pk, NC 27709 USA

来源：

CANCER INVESTIGATION | 2023年 / 41卷 / 06期

关键词：

Biomarker; circulating tumor DNA; non-small cell lung cancer; small cell lung cancer; lung cancer; CIRCULATING TUMOR DNA; TYROSINE KINASE INHIBITORS; CELL-FREE DNA; ADVANCED NSCLC PATIENTS; EGFR MUTATIONS; LIQUID BIOPSY; TARGETED THERAPY; DYNAMIC CHANGES; PLASMA; ADENOCARCINOMA;

D O I：

10.1080/07357907.2023.2220820

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This systematic review with embedded meta-analysis aimed to evaluate the clinical utility of circulating tumor DNA (ctDNA) in lung cancer. After screening and review of the Embase database search, 111 studies from 2015 to 2020 demonstrated ctDNA's value in prognostication/monitoring disease progression, mainly in patients with advanced/metastatic disease and non-small cell lung cancer. ctDNA positivity/detection at any time point was associated with shorter progression-free survival and overall survival, whereas ctDNA clearance/decrease during treatment was associated with a lower risk of progression and death. Validating these findings and addressing challenges regarding ctDNA testing integration into clinical practice will require further research.

引用

页码：571 / 592

页数：22

共 142 条

[71] Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma [J].

Liu, Yutao ;

Feng, Yu ;

Hou, Ting ;

Lizaso, Analyn ;

Xu, Feng ;

Xing, Puyuan ;

Wang, Hongyu ;

Kang, Qiaolin ;

Zhang, Lu ;

Shi, Yuankai ;

Hu, Xingsheng .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) :2356-2366

[72] Presence of allele frequency heterogeneity defined by ctDNA profiling predicts unfavorable overall survival of NSCLC [J].

Liu, Zhichao ;

Xie, Zhanhong ;

Zhao, Shen ;

Ye, Dawei ;

Cai, Xluyu ;

Cheng, Bo ;

Li, Caichen ;

Xiong, Shan ;

Li, Jianfu ;

Liang, Hengrui ;

Chen, Zisheng ;

Liang, Peng ;

Liu, Jun ;

He, Jianxing ;

Liang, Wenhua .

TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) :1045-1050

[73] Targeted therapy in advanced non-small cell lung cancer: current advances and future trends [J].

Majeed, Umair ;

Manochakian, Rami ;

Zhao, Yujie ;

Lou, Yanyan .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)

[74] KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer [J].

Mastoraki, Sofia ;

Balgkouranidou, Ioanna ;

Tsaroucha, Emily ;

Klinakis, Apostolos ;

Georgoulias, Vassilis ;

Lianidou, Evi .

MOLECULAR ONCOLOGY, 2021, 15 (09) :2412-2422

[75] Circulating Tumor DNA Analysis in Patients With Cancer American Society of Clinical Oncology and College of American Pathologists Joint Review [J].

Merker, Jason D. ;

Oxnard, Geoffrey R. ;

Compton, Carolyn ;

Diehn, Maximilian ;

Hurley, Patricia ;

Lazar, Alexander J. ;

Lindeman, Neal ;

Lockwood, Christina M. ;

Rai, Alex J. ;

Schilsky, Richard L. ;

Tsimberidou, Apostolia M. ;

Vasalos, Patricia ;

Billman, Brooke L. ;

Oliver, Thomas K. ;

Bruinooge, Suanna S. ;

Hayes, Daniel F. ;

Turner, Nicholas C. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (10) :1242-1253

[76] Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer [J].

Mezquita, Laura ;

Swalduz, Aurelie ;

Jovelet, Cecile ;

Ortiz-Cuaran, Sandra ;

Howarth, Karen ;

Planchard, David ;

Avrillon, Virginie ;

Recondo, Gonzalo ;

Marteau, Solene ;

Benitez, Jose Carlos ;

De Kievit, Frank ;

Plagnol, Vincent ;

Lacroix, Ludovic ;

Odier, Luc ;

Rouleau, Etienne ;

Fournel, Pierre ;

Caramella, Caroline ;

Tissot, Claire ;

Adam, Julien ;

Woodhouse, Samuel ;

Nicotra, Claudio ;

Auclin, Edouard ;

Remon, Jordi ;

Morris, Clive ;

Green, Emma ;

Massard, Christophe ;

Perol, Maurice ;

Friboulet, Luc ;

Besse, Benjamin ;

Saintigny, Pierre .

JCO PRECISION ONCOLOGY, 2020, 4 :272-282

[77] Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study [J].

Minari, Roberta ;

Mazzaschi, Giulia ;

Bordi, Paola ;

Gnetti, Letizia ;

Alberti, Giorgia ;

Altimari, Annalisa ;

Gruppioni, Elisa ;

Sperandi, Francesca ;

Parisi, Claudia ;

Guaitoli, Giorgia ;

Bettelli, Stefania ;

Longo, Lucia ;

Bertolini, Federica ;

Pagano, Maria ;

Bonelli, Candida ;

Tagliavini, Elena ;

Nicoli, Davide ;

Ubiali, Alessandro ;

Zangrandi, Adriano ;

Trubini, Serena ;

Proietto, Manuela ;

Fiorentino, Michelangelo ;

Tiseo, Marcello .

CLINICAL LUNG CANCER, 2020, 21 (05) :E464-E473

[78] Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer [J].

Moding, Everett J. ;

Liu, Yufei ;

Nabet, Barzin Y. ;

Chabon, Jacob J. ;

Chaudhuri, Aadel A. ;

Hui, Angela B. ;

Bonilla, Rene F. ;

Ko, Ryan B. ;

Yoo, Christopher H. ;

Gojenola, Linda ;

Jones, Carol D. ;

He, Jianzhong ;

Qiao, Yawei ;

Xu, Ting ;

Heymach, John V. ;

Tsao, Anne ;

Liao, Zhongxing ;

Gomez, Daniel R. ;

Das, Millie ;

Padda, Sukhmani K. ;

Ramchandran, Kavitha J. ;

Neal, Joel W. ;

Wakelee, Heather A. ;

Loo, Billy W., Jr. ;

Lin, Steven H. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

NATURE CANCER, 2020, 1 (02) :176-+

[79] Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy [J].

Mok, Tony ;

Wu, Yi-Long ;

Lee, Jin Soo ;

Yu, Chong-Jen ;

Sriuranpong, Virote ;

Sandoval-Tan, Jennifer ;

Ladrera, Guia ;

Thongprasert, Sumitra ;

Srimuninnimit, Vichien ;

Liao, Meilin ;

Zhu, Yunzhong ;

Zhou, Caicun ;

Fuerte, Fatima ;

Margono, Benjamin ;

Wen, Wei ;

Tsai, Julie ;

Truman, Matt ;

Klughammer, Barbara ;

Shames, David S. ;

Wu, Lin .

CLINICAL CANCER RESEARCH, 2015, 21 (14) :3196-3203

[80] Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer [J].

Moon, Seong Mi ;

Kim, Ji-Ho ;

Kim, Seong Keun ;

Kim, Seonwoo ;

Kwon, Hyuk-Jung ;

Bae, Jin-Sik ;

Lee, Sunghoon ;

Lee, Hye Seon ;

Choi, Mi-Young ;

Jeon, Byung Hee ;

Jeong, Byeong-Ho ;

Lee, Kyungjong ;

Kim, Hong Kwan ;

Kim, Jhingook ;

Um, Sang-Won .

ANTICANCER RESEARCH, 2020, 40 (06) :3435-3444

← 3 4 5 6 7 8 9 10 11 12 →